Drouet L - Search Results

1

Wine constituents inhibit thrombosis but not atherogenesis in C57BL/6 apolipoprotein E-deficient mice.

Soulat T, Philippe C, Bal dit Sollier C, Brézillon C, Berge N, Teissedre PL, Callebert J, Rabot S, Drouet L. Soulat T, et al. Among authors: drouet l. Br J Nutr. 2006 Aug;96(2):290-8. doi: 10.1079/bjn20061818. Br J Nutr. 2006. PMID: 16923223

2

Reduced thrombus cohesion in an ex vivo human model of arterial thrombosis induced by clopidogrel treatment: kinetics of the effect and influence of single and double loading-dose regimens.

Bal dit Sollier C, Mahé I, Berge N, Simoneau G, Bergmann JF, Drouet L. Bal dit Sollier C, et al. Among authors: drouet l. Thromb Res. 2003;111(1-2):19-27. doi: 10.1016/s0049-3848(03)00403-1. Thromb Res. 2003. PMID: 14644074

3

Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis.

Bal dit Sollier C, Kang C, Berge N, Herault JP, Bonneau M, Herbert JM, Drouet L. Bal dit Sollier C, et al. Among authors: drouet l. J Thromb Haemost. 2004 Jun;2(6):925-30. doi: 10.1111/j.1538-7836.2004.00719.x. J Thromb Haemost. 2004. PMID: 15140128 Free article.

4

[The basis of platelets: platelets and atherothrombosis: an understanding of the lack of efficacy of aspirin in peripheral arterial disease (PAD) and diabetic patients].

Drouet L, Bal dit Sollier C, Henry P. Drouet L, et al. Drugs. 2010 Nov 1;70 Suppl 1:9-14. doi: 10.2165/00000005-000000000-00000. Drugs. 2010. PMID: 20977287 Review. Japanese.

5

[Is fibrinogen a predictor or a marker of the risk of cardiovascular events?].

Drouet L, Bal dit Sollier C. Drouet L, et al. Therapie. 2005 Mar-Apr;60(2):125-36. doi: 10.2515/therapie:2005017. Therapie. 2005. PMID: 15969315 Review. French.

6

[Besides fibrinogen, are haemostatic, coagulation and/or fibrinolytic parameters predictors or markers of the risk of cardiovascular events?].

Drouet L, Bal dit Sollier C. Drouet L, et al. Therapie. 2005 Mar-Apr;60(2):137-47. doi: 10.2515/therapie:2005018. Therapie. 2005. PMID: 15969316 Review. French.

7

In vivo pig models of venous thrombosis mimicking human disease.

Kang C, Bonneau M, Brouland JP, Bal dit Sollier C, Drouet L. Kang C, et al. Among authors: drouet l. Thromb Haemost. 2003 Feb;89(2):256-63. Thromb Haemost. 2003. PMID: 12574804

8

Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann's thrombasthenia: studies in an ex vivo perfusion chamber model.

Hainaud P, Brouland JP, André P, Simoneau G, Bal Dit Sollier C, Drouet L, Caen J, Bellucci S. Hainaud P, et al. Among authors: drouet l. Br J Haematol. 2002 Dec;119(4):998-1004. doi: 10.1046/j.1365-2141.2002.03966.x. Br J Haematol. 2002. PMID: 12472580 Free article.

9

[Fibrinogen: factor and marker of cardiovascular risk].

Drouet L, Bal Dit Sollier C. Drouet L, et al. J Mal Vasc. 2002 Jun;27(3):143-56. J Mal Vasc. 2002. PMID: 12232531 Review. French.

10

Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic events.

Drouet L, Bal Dit Sollier C. Drouet L, et al. Eur J Clin Invest. 2005 Mar;35 Suppl 1:21-6. doi: 10.1111/j.0960-135X.2005.01453.x. Eur J Clin Invest. 2005. PMID: 15701144 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters